Title: Drugs Used to Treat Schizophrenia
1Drugs Used to TreatSchizophrenia
2Positive symptoms of schizophrenia
- Delusions
- Hallucinations
- Bizarre behaviors
- Dissociated or fragmented thoughts
- Incoherence
- illogicality
3Negative symptoms of schizophrenia
- Blunted affect
- Impaired emotional responsiveness
- Apathy
- Loss of motivation interest
- Social withdrawal
4Why are these symptoms important in drug therapy?
- Classic agents affect primarily positive
symptoms, while the atypical antipsychotics
relieve both positive and negative symptoms
5Neurotransmitters involved in the pathogenesis of
schizophrenia
- Dopamine antipsychotics work by being
antagonists of dopamine - Glutamate a glutamate-NMDA receptor deficiency
may explain negative symptoms cognitive
dysfunction - Serotonin serotoninergic activity may be a
complementary action to dopaminergic blockade
also may be a serotonin-glutamate
interactiondrug-induced serotonin blockade
functions to limit glutamate release
6Are all antipsychotics neuroleptics?
- Neuroleptic means to take control of the
neuron. - Traditional antipsychotics were previously viewed
to be inseparable from extrapyramidal side
effects. The neuroleptic dose was gradually
increased to the level that produced these
effectsa neuroleptic state. - Atypical antipsychotics can produce effects at
doses that do not produce motor side effects and
do not produce a neuroleptic state.
7Primary clinical differences between traditional
and atypical antipsychotics
- Separation of side effects and antipsychotic
effects - Traditional block dopamineeffective for positive
symptoms Atypical block dopamine plus action on
serotonin glutamateeffective for negative and
symptoms and cognitive deficits as well
8What is a tranquilizer?
- Tranquilizers are typically thought of as agents
that induce a peaceful, tranquil, calm, or
pleasant state - It is important to distinguish between two types
- Minor (benzodiazapines) reduce anxiety, produce
calm, pleasant state - Major (antipsychotics) psychological effects
produced are seldom pleasant or euphoric
especially unpleasant dysphoric with
nonpsychotic persons
9Mechanisms of action of traditional antipsychotics
- Block dopamine D2 receptors
10Mechanisms of Atypical Antipsychotics
- Clozapine blocks serotonin 5-HT2 receptors
weak blocker of dopamine - Olanzapine blocks dopamine D2 and serotonin 5-HT
receptors - Sertindole effects a variety of dopamine and
serotonin receptors - Quetiapine ziprasidone antagonists at
neurotransmitter receptors including 5-HT1A,
5-HT2, D1, D2, histamine, and adrenergic
11Side Effects of Phenothiazines
- Altered pigmentation of the skin
- Pigment deposits in the retina
- Permanently impaired vision
- Decreased pituitary function
- Menstrual dysfunction
- Allergic reactions, which include liver
dysfunction and blood disorders
12Clozapine
- It is the only antipsychotic drug that is
effective in treating treatment-resistant
schizophrenics. - It is clinically superior to traditional
antipsychotics - It relieves many of the negative symptomatology
of schizophrenia, and lacks many of the
extrapyramidal side effects of standard
neuroleptics
13Chlorpromazine
- Chlorpromazine was first used to allay fears and
anxieties in surgery patients the night before
surgery. - It was found to be remarkably effective in
alleviating the clinical manifestations of the
psychotic process.
14Olanzapine
- Olanzapine has been shown to be produce
improvements in positive and negative symptoms of
schizophrenia. - Extrapyramidal side effects are only rarely
observed. - Results suggest olanzapine may be more effective
and better tolerated than traditional
antipsychotics in less severely impaired patients.
15Atypical Antipsychotic Drugs
- Molindone, loxapine, clozapine, risperidone,
pimozide, olanzapine, sertindole, quetiapine, and
ziprazadone - They are all alternatives to phenothiazines, and
the all are unique in action.
16Amisulpride
- This drug has a unique neurochemical and
psychopharmacological profile it has high
selectivity for blocking dopamine D2 D3
receptor subtypes in the limbic system, but not
the basal ganglia, and it blocks functional
responses mediated by those receptors.
17Amisulpride
- As a dopamine blocker, one would predict that it
would exert actions similar to those of the
traditional antipsychotics, however, amisulpride
is twice as selective for D3 receptors than for
D2 receptors at low doses it blocks presynaptic
dopamine autoreceptors while postsynaptic
dopamine receptor D2 antagonism becomes apparent
at higher doses.
18Amisulpride
- This dual action results in increased dopamine
activity in the mesolimbic system at low doses
and an antipsychotic action at higher doses, with
a low incidence of extrapyramidal side effects.